-
1دورية أكاديمية
المؤلفون: Kenneth Down (1523722), Augustin Amour (1523692), Niall A. Anderson (4590892), Nick Barton (363978), Sebastien Campos (3847891), Edward P. Cannons (1840267), Cole Clissold (10498431), Maire A. Convery (1840459), John J. Coward (11422026), Kevin Doyle (2324602), Birgit Duempelfeld (4174972), Christopher D. Edwards (2342788), Michael D. Goldsmith (11422029), Jana Krause (2885033), David N. Mallett (1494217), Grant A. McGonagle (1330743), Vipulkumar K. Patel (2342794), James Rowedder (6112244), Paul Rowland (1523731), Andrew Sharpe (3575186), Srividya Sriskantharajah (9261425), Daniel A. Thomas (1932538), Douglas W. Thomson (1266420), Sorif Uddin (2891561), J. Nicole Hamblin (1523686), Edith M. Hessel (8267715)
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Neuroscience, Pharmacology, Immunology, Cancer, Infectious Diseases, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, positive heteroaromatic amine, orally bioavailable inhibitor, avoid glutathione trapping, clinical candidate compound, 31 b, highly selective compound, highly selective, highly potent, trp760 led, sulfonamide followed, enhance potency, embedded ames, 45 mg
-
2
المؤلفون: Kenneth Down (1523722), Augustin Amour (1523692), Niall A. Anderson (4590892), Nick Barton (363978), Sebastien Campos (3847891), Edward P. Cannons (1840267), Cole Clissold (10498431), Maire A. Convery (1840459), John J. Coward (11422026), Kevin Doyle (2324602), Birgit Duempelfeld (4174972), Christopher D. Edwards (2342788), Michael D. Goldsmith (11422029), Jana Krause (2885033), David N. Mallett (1494217), Grant A. McGonagle (1330743), Vipulkumar K. Patel (2342794), James Rowedder (6112244), Paul Rowland (1523731), Andrew Sharpe (3575186), Srividya Sriskantharajah (9261425), Daniel A. Thomas (1932538), Douglas W. Thomson (1266420), Sorif Uddin (2891561), J. Nicole Hamblin (1523686), Edith M. Hessel (8267715)
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Neuroscience, Pharmacology, Immunology, Cancer, Infectious Diseases, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, positive heteroaromatic amine, orally bioavailable inhibitor, avoid glutathione trapping, clinical candidate compound, 31 b, highly selective compound, highly selective, highly potent, trp760 led, sulfonamide followed, enhance potency, embedded ames, 45 mg